• Home
  • Simtra BioPharma Solutions
6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 10H2
Book a meeting

Simtra BioPharma Solutions

About Simtra BioPharma Solutions

As the premier, independently owned CDMO with more than 65 years of sterile injectable manufacturing expertise, Simtra BioPharma Solutions delivers advanced cGMP sterile fill and finish to the highest standard in the industry.

Our focused approach is backed by technical rigor, collaborative integrations, and a future-forward mindset designed to support our customers strategic objectives.

Biotech and pharmaceutical companies partner with Simtra when they need to take their molecule to market, whether launching their innovation globally, improving their formulation, or proactively mitigating risk to help grow their business.

Our teams of ten...

Read more Show less
Certifications
  • CE
    CE
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 10H2
  • Country/Region:
    United States
  • On CPHI since:
    2024
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Primary activities
Biopharmaceutical
Contract Manufacturer
Contact info
  • +1 812 3554255
  • Website
  • 400 Interpace Parkway, Bldg C, Suite 270, 2nd Floor, 07054, Parsippany, NJ, United States
Show contact info Hide contact info

Simtra BioPharma Solutions Resources (3)

  • Our Capabilities- Your Partner for Vital Injectable Products

    Brochure Our Capabilities- Your Partner for Vital Injectable Products

    With 65+ years focused exclusively on sterile injectables, Simtra BioPharma Solutions brings integrated scientific, technical and manufacturing expertise — from development through global commercial fill/finish. As an agile, independent contract development and manufacturing organization (CDMO), we partner with pharma and biotech companies to reduce risk, scale with confidence and accelerate delivery of high-quality injectables to patients.
  • Connecting All Your Dots. Simtra's dedicated bioconjugation suite is coming soon.

    Brochure Connecting All Your Dots. Simtra's dedicated bioconjugation suite is coming soon.

    Simtra BioPharma Solutions is extending its proven sterile injectable formulation and fill/finish expertise upstream into bioconjugation — creating a more integrated drug substance (DS) and drug product (DP) solution under one roof. 

    Designed to be platform-agnostic, Simtra enables customers to select the conjugation science that best fits their molecule, while benefiting from a single, integrated CDMO partner. 


    By reducing handoffs and simplifying development, Simtra helps accelerate the path from DS to DP — without the technical trade-offs.


    Simtra's dedicated bioconjugation suite is coming soon.
  • From Lab to Launch Your Partner At Every Step

    Brochure From Lab to Launch Your Partner At Every Step

    As a leading contract development and manufacturing organization (CDMO) with a singular focus on sterile injectables, Simtra BioPharma Solutions provides customized end-to-end services that meet the unique challenges of manufacturing injectables, from product development to clinical and commercial production at any scale.